
Focus And Scope
This journal is dedicated to publishing high-quality, peer-reviewed original research articles in the field of pharmaceutical sciences. It aims to provide a scientific platform for researchers, academics, and practitioners to disseminate novel findings that contribute to the advancement of pharmacy practice, pharmaceutical technology, and health outcomes.
Manuscript Types
Jurnal Ilmiah Farmasi Simplisia (JIFS) accepts original research articles and does not consider review papers or short communications.
Scope
The scope of the journal includes, but is not limited to, the following areas:
Pharmaceutical Technology:
Studies related to drug formulation, drug delivery systems (including nanotechnology-based systems), pharmaceutical processing, quality control, and physicochemical characterization of dosage forms.
Community Pharmacy:
Research on pharmaceutical care, patient adherence, and the expanding role of pharmacists in community settings.
Cosmetics and Cosmeceuticals:
Research on the formulation, characterization, safety, efficacy, and regulatory aspects of cosmetic and cosmeceutical products, particularly those derived from natural resources.
Clinical Pharmacy:
Studies evaluating pharmacotherapy, clinical outcomes, drug utilization, medication safety, and evidence-based clinical practices involving pharmacists in multidisciplinary healthcare teams.
Traditional Medicine:
Scientific investigations on natural products, herbal medicines, ethnopharmacology, and phytochemical studies, including the evaluation of efficacy, safety, and mechanisms of action.
Molecular Docking and Computational Studies:
In silico research supporting drug discovery, drug–target interactions, and pharmacological mechanisms of bioactive compounds, preferably supported by experimental validation.
The journal encourages interdisciplinary research and innovative approaches that integrate experimental and computational methods to address current challenges in pharmaceutical sciences and contribute to the development of effective and safe therapeutic products.

